Analysis of mutation spectrum of COL1A1 and COL1A2 genes using massively parallel sequencing in patients with osteogenesis imperfecta in the Tomsk region

Using massively parallel sequencing, the COL1A1 and COL1A2 genes were analyzed in 16 patients from 10 families with osteogenesis imperfecta types I, III, and IV. To analyze the mutations in these genes, a panel of primers was developed for sequencing the complete gene sequence. As a result of the work, 10 mutations were revealed: six of them are in the COL1A1 gene, four mutations in the COL1A2 gene. All mutations, except one, were previously described in the literature and were found in patients with various types of osteogenesis imperfecta. Missense mutations were identified in five families, nonsense mutations in two families, splice site mutations in two cases, and a frameshift mutation in one patient. Unique mutations that were not repeated in unrelated patients were found in all families. The revealed high heterogeneity of the spectrum of mutations in the COL1A1 and COL1A2 genes in osteogenesis imperfecta indicates the effectiveness of using MPS-based methods for the diagnosis of this pathology.

osteogenesis imperfecta, massively parallel sequencing, COL1A1 gene, COL1A2 gene

1. Burtsev M.E., Frolov A.V., Logvinov A.N., Ilyin D.O., Korolev A.V. Sovremennyy podkhod k diagnostike i lecheniyu detey s nesovershennym osteogenezom [Current approach to diagnosis and treatment of children with osteogenesis imperfect]. Ortopediya, travmatologiya i vosstanovitel’naya khirurgiya detskogo vozrasta [Pediatric Traumatology, Orthopaedics and Reconstructive Surgery]. 2019;7(2):87102 (In Russ.)

2. Brizola E, Félix TN, Shapiro JR. Pathophysiology and therapeutic options in osteogenesis imperfecta: an update. Research and Reports in Endocrine Disorders. 2016;6:17–30

3. Boban L, Rod ER, Plečko M, et al. Molecular basis of osteogenesis imperfect and future medical treatment. Paediatr Croat. 2017;61:147–55

4. Kang H, Aryal ACS, Marini JC. Osteogenesis imperfecta: new genes reveal novel mechanisms in bone dysplasia. Transl Res. 2017 Mar;181:27–48

5. Marini JC, Forlino A, Bächinger HP, et al. Osteogenesis imperfecta. Nat Rev Dis Primers. 2017 Aug 18;3:17052

6. Palomo T, Vilaça T, Lazaretti-Castro M. Osteogenesis imperfecta: diagnosis and treatment. Curr Opin Endocrinol Diabetes Obes. 2017 Dec;24(6):381-388

7. Van Dijk FS, Sillence DO. Osteogenesis imperfecta: clinical diagnosis, nomenclature and severity assessment. Am J Med Genet A. 2014 Jun;164A(6):1470–1481

8. Ryzhkova O.P., Kardymon O.L., Prohorchuk E.B., Konovalov F.A., Maslennikov A.B., Stepanov V.A., Afanasyev A.A., Zaklyazminskaya E.V., Rebrikov D.V., Savostianov K.V., Glotov A.S., Kostareva A.A., Pavlov A.E., Golubenko M.V., Polyakov A.V., Kutsev S.I. Rukovodstvo po interpretatsii dannykh posledovatel’nosti DNK cheloveka, poluchennykh metodami massovogo parallel’nogo sekvenirovaniya (MPS) (redaktsiya 2018, versiya 2) [Guidelines for the interpretation of massive parallel sequencing variants (update 2018, v2)]. Meditsinskaya genetika [Medical Genetics].2019;18(2):3–23 (In Russ.)

9. Potekhina Y. Struktura i funktsii kollagena [Collagen Structure and Function]. Rossiyskiy osteopaticheskiy zhurna. [Russian Osteopathic Journal]. 2016;1-2(32-33):87–99 (In Russ.)

10. Engel J, Bächinger HP. Structure, Stability and Folding of the Collagen Triple Helix. Top Curr Chem. 2005;247:7–33

11. Chhum P, Yu H, An B, et al. Consequences of Glycine Mutations in the Fibronectin-binding Sequence of Collagen. J Biol Chem. 2016 Dec 30;291(53):27073–27086.

12. Nadyrshina, D.D., Khusainova, R.I. & Khusnutdinova, E.K. Studies of type I collagen (COL1A1) α1 chain in patients with osteogenesis imperfecta. Russ J Genet. 2012; 48: 321–328

13. Stephen J, Shukla A, Dalal A, et al. Mutation spectrum of COL1A1 and COL1A2 genes in Indian patients with osteogenesis imperfecta. Am J Med Genet A. 2014 Jun;164A(6):1482–1489

14. Zhytnik L, Maasalu K, Reimann E, et al. Mutational analysis of COL1A1 and COL1A2 genes among Estonian osteogenesis imperfecta patients. Hum Genomics. 2017 Aug 15;11(1):19